Hikma Pharmaceuticals (HKMPF) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Hikma Pharmaceuticals

    PNK: HKMPF · Real-Time Price · USD
    26.93
    0.73 (2.80%)
    At close: May 07, 2025, 12:33 PM

    Hikma Pharmaceuticals Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 188M 205M 270M 426M
    Short-Term Investments
    		 25M 24M 22M 24M
    Long-Term Investments
    		 61.94M 65M 52M 46M
    Other Long-Term Assets
    		 326.06M 274M -192M -183M
    Receivables
    		 905M 789M 777M 781M
    Inventory
    		 986M 891M 776M 695M
    Other Current Assets
    		 86M 119M 80M 103M
    Total Current Assets
    		 2.26B 2.1B 2B 2.09B
    Property-Plant & Equipment
    		 1.33B 1.14B 1.08B 1.15B
    Goodwill & Intangibles
    		 1.16B 1.1B 1.12B 892M
    Total Long-Term Assets
    		 2.87B 2.58B 2.26B 2.08B
    Total Assets
    		 5.13B 4.68B 4.47B 4.37B
    Account Payables
    		 358M 309M 291M 262M
    Deferred Revenue
    		 n/a n/a -148M -121M
    Short-Term Debt
    		 642M 150M 139M 112M
    Other Current Liabilities
    		 528M 481M 366M 328M
    Total Current Liabilities
    		 1.98B 1.34B 1.08B 1.02B
    Long-Term Debt
    		 607M 975M 1.07B 651M
    Other Long-Term Liabilities
    		 133.03M 102M -61M -74M
    Total Long-Term Liabilities
    		 834M 1.13B 1.07B 651M
    Total Liabilities
    		 2.81B 2.47B 2.32B 1.91B
    Total Debt
    		 1.31B 1.19B 1.28B 846M
    Common Stock
    		 40M 40M 40M 42M
    Retained Earnings
    		 2.36B 2.16B 2.09B 2.19B
    Comprehensive Income
    		 n/a n/a -279M -60M
    Shareholders Equity
    		 2.31B 2.2B 2.13B 2.45B
    Total Investments
    		 87M 83M 74M 70M

    Add to Watchlist